Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 27:26:e948329.
doi: 10.12659/AJCR.948329.

One Patient with 3 Antibody-Confirmed Neurological Autoimmune Syndromes: A Case Report and Review of the Literature

Affiliations
Review

One Patient with 3 Antibody-Confirmed Neurological Autoimmune Syndromes: A Case Report and Review of the Literature

Lauren A Nguyen et al. Am J Case Rep. .

Abstract

BACKGROUND The occurrence of multiple autoimmune neurological disorders in one patient is rare. Here, we present the case of a woman who exhibited clinical features and antibody titers consistent with myasthenia gravis (MG), neuromyelitis optica (NMO), and anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. CASE REPORT A 37-year-old woman with a 10-year history of MG presented with a sudden loss of central vision in her right eye. Magnetic resonance imaging (MRI) revealed new enhancement of the right optic nerve, and additional cervical and thoracic spine scans showed continuous demyelination of the central cord. Given these findings, a primary demyelinating condition was suspected, and an NMO antibody test confirmed the diagnosis. Two years later, the patient developed significant behavioral changes, including neglecting her usual activities and displaying diminished responsiveness. She became mute and uncooperative with commands. Based on clinical suspicion of anti-NMDAR encephalitis, a comprehensive work-up revealed the presence of NMDAR antibodies, confirming the diagnosis. The patient was treated with plasma exchange, resulting in a marked improvement in her encephalopathy. CONCLUSIONS Over 12 years, this patient developed clinical manifestations of 3 distinct neurological autoimmune disorders. This case underscores the critical need for clinicians to remain alert to overlapping neurological conditions, enabling timely diagnoses and interventions that can help improve clinical outcomes and prevent unnecessary delays in treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1
Figure 1
Fluid-attenuated inversion recovery sequence MRI of the brain showing non-enhancing T2 hyperintensities in the right gangliocapsular region, both frontal lobes, and the right insular cortex.

References

    1. Fichtner ML, Jiang R, Bourke A, et al. Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology. Front Immunol. 2020;11:776. - PMC - PubMed
    1. Bukhari W, Barnett MH, Prain K, Broadley SA. Molecular pathogenesis of neuromyelitis optica. Int J Mol Sci. 2012;13(10):12970–93. - PMC - PubMed
    1. Dalmau J, Armangué T, Planagumà J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045–57. - PubMed
    1. Christensen PB, Jensen TS, Tsiropoulos I, et al. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand. 1995;91(3):192–95. - PubMed
    1. Fang F, Sveinsson O, Thormar G, et al. The autoimmune spectrum of myasthenia gravis: A Swedish population-based study. J Intern Med. 2015;277(5):594–604. - PubMed

MeSH terms